Bindex strengthens its position in the world

The world's first pocket-sized diagnostic device for osteoporosis, Bindex, developed by the Kuopio medical device manufacturer Bone Index, is gaining a foothold in the world. According to a new medical study, Bindex works reliably and its measurement accuracy meets international requirements. The device can be recommended for use in primary health care.

The results of the large international study were published at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases held in late March in Milan. The study measured 1,316 women aged over 50 at a total of nine locations in Finland and the USA. The study revealed that 70 per cent of the women could have been reliably diagnosed in primary health care with the Bindex device and only 30 per cent would require further assessment in specialist health care.

"The results are similar to those in our original research data. The large amount of data from different countries in this study strengthens our market position significantly," says the delighted Managing Director of Bone Index, Ossi Riekkinen.

In the EU region, bone fractures caused by osteoporosis cost society as much as 40 billion euros every year. One of the biggest problems remains the poor availability of diagnostic tests. Hitherto, there has not been a reliable and economical method for screening and diagnosis of osteoporosis, so patients have had to be referred to a hospital for tests.

"Osteoporosis is a disease that makes a person susceptible to bone fractures. In Finland, there are an estimated 400,000 people suffering from osteoporosis, only a quarter of whom are aware that they have the disease. Responsibility for providing diagnosis and treatment of osteoporosis should be with primary health care," says osteoporosis researcher Professor Heikki Kröger of the University of Eastern Finland.

For more information:   Managing Director Ossi Riekkinen,,

                                      +358 50 363 2797,

                                      Professor Heikki Kröger,, +358 (0)17 172 602

‹ Back to previous page

Bone Index Ltd.